Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer

Cancer Chemotherapy and Pharmacology

Volumn 51, Issue 1, 2003, Pages 29-35

  Hirano, Yasuhiro ^a   Kageyama, Shinji ^a   Ushiyama, Tomomi ^a   Suzuki, Kazuo ^a   Fujita, Kimio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 Fluorouracil; Dihydropyrimidine dehydrogenase; Thymidine phosphorylase; Transitional cell cancer

Indexed keywords

ANGIOGENIC FACTOR; DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; THYMIDINE PHOSPHORYLASE;

ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOENZYMATIC ASSAY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR GROWTH;

CARCINOMA, TRANSITIONAL CELL; DIHYDROURACIL DEHYDROGENASE (NADP); FLUOROURACIL; HUMANS; OXIDOREDUCTASES; THYMIDINE PHOSPHORYLASE; URINARY BLADDER NEOPLASMS;

EID: 0037217903     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-002-0520-9     Document Type: Article

References (25)

1. Etienne MC, Cheradame S, Fischel JL, Formento P, Dassonville O, Renee N, Schneider M, Thyss A, Demard F, Milano G (1995) Response to fluorouracil therapy in cancer patients: The role of tumoral dihydropyrimidine dehydrogenase activity. J Clin Oncol 13:1663
2. Fukushima M, Nomura H, Murakami Y, Shirasaka T, Aiba K (1996) Estimation of pathways of 5-fluorouracil anabolism in human cancer cells in vitro and in vivo. Jpn J Cancer Chemother 23:721
3. Guimbaud R, Guichard S, Dusseau C, Lochon I, Bugat, R, Chatelut, E, Canal P (2000) Dihydropyrimidine dehydrogenase activity in normal, inflammatory and tumour tissues of colon and liver in humans. Cancer Chemother Pharmacol 45:477
4. Hartmann KU, Heidelberger C. (1961) Studies on fluorinated pyrimidines. J Biol Chem 236:3006
5. Hirano Y, Ushiyama T, Suzuki K, Fujita K (1999) Clinical application of in vitro chemosensitivity test with the histoculture drug response assay for urological cancers: Wide distribution of inhibition rates in bladder cancer and renal cell cancer. Urol Res 27:483
6. Hirano Y, Kageyama S, Ushiyama T, Suzuki K, Fujita K (2000) Thymidine phosphorylase activity in transitional cell cancer: Relation to histological parameters and chemosensitivity to fluorouracil-related drugs. Anticancer Res 20:4315
7. Ikenaka K, Shirasaka T, Kitano S, Fujii S (1979) Effect of uracil on metabolism of 5-fluorouracil in vitro. Gann 70:355
8. Imazono Y, Takebayashi Y, Nishiyama K, Akiba S, Miyadera K, Yamada Y, Akiyama S, Ohi Y (1997) Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 15:2570
9. Ishikawa F, Miyazono K, Hellman U, Drexler M, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338:557
10. Ishikawa Y, Kubota T, Otani Y, Watanabe M, Tatsuo T, Kumai K, Takechi T, Okabe H, Fukushima M, Kitajima M (1999) Thymidylate synthase and dihydropyrimidine dehydrogenase levels in gastric cancer. Anticancer Res 19:5635
11. Kubota Y, Hosaka M, Fukushima S (1993) Prophylactic oral UFT therapy for superficial bladder cancer. Cancer 71:1842
12. Lowry OH, Rosebroough NJ, Farr AC, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265
13. Marchetti S, Chazal M, Dubreuil A, Fischel JL, Etienne MC, Milano G (2001) Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis. Br J Cancer 85:439
14. McLeod HL, Sludden J, Murray GI, Keenan RA, Davidson AI, Park K, Koruth M, Cassidy J (1998) Characterization of dihydropyrimidine dehydrogenase in human colorectal tumors. Br J Cancer 77:461
15. Milano G, Fischel JL, Etienne MC (1994) Inhibition dihydropyrimidine dehydrogenase by alpha-interferon: Experimental data on human tumor cell lines. Cancer Chemother Pharmacol 34:147
16. Mizutani Y, Okada Y, Yoshida O (1997) Expression of platelet-derived endothelial cell growth factor in bladder carcinoma. Cancer 79:1190
17. Mizutani Y, Wada H, Fukushima M, Yoshida O, Ukimura O, Kawauchi A, Miki T (2001) The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer. Eur J Cancer 37:569
18. Naguib FMN, El Kouni MH, Cha S (1985) Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res 45:5405
19. Ohtsu A, Baba H, Sakata Y, Mitachi Y, Horikoshi N, Sugimachi K, Taguchi T (2000) Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group. Br J Cancer 83:141
20. Salonga D, Danenberg KD, Johonson M, Metzger R, Groshen S, Leichman CG, Leichman L, Diasio RB, Danenberg PV (2000) Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dehydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 6:1322
21. Sawase K, Nomata K, Kanetake H, Saito Y (1998) The expression of platelet-derived endothelial cell growth factor in human bladder cancer. Cancer Lett 130:35
22. Shirasaka T, Shimamoto Y, Fukushima M (1993) Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its anti-tumor activity in rats. Cancer Res 53:4004
23. Shirasaka T, Shimamato Y, Ohshimo H, Yamaguchi M, Kato T, Yonekura K, Fukushima M (1996) Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs 7:548
24. Uetake H, Ichikawa W, Takechi T, Fukushima M, Nihei Z, Sugihara K (1999) Relationship between intratumoral dihydropyrimidine dehydrogenase activity and gene expression in human colorectal cancer. Clin Cancer Res 5:2836
25. Woodman PW, Sarrif AM, Heidelberger C (1980) Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2?-deoxyuridine. Cancer Res 40:507